Literature DB >> 7029655

Isolation of prostacyclin from whole blood.

V Skrinska, F V Lucas.   

Abstract

A method was development for the isolation of prostacyclin (PGI2) from whole blood in a fraction suitable for high pressure liquid chromatography (HPLC) separation of PGI2 and 6-keto-prostaglandin F1 alpha (6-K-PGF1 alpha). Prostacyclin was stabilized in whole blood by rapidly raising the pH to 10 with Na2CO3 and cooling the samples to 0 degree C. Under these conditions, 2.9% hydrolysis was observed after 20 min. Reverse phase extraction columns were used to directly extract both PGI2 and 6-K-PGF1 alpha from the alkaline plasma with recoveries of greater than 95% using an acetonitrile/2mM Na2B4O7, pH 10, 40/60 elution solvent mixture. An additional 1.7% hydrolysis was found during the column extraction procedure. Final separation of PGI2 and 6-K-PGF1 alpha was performed with HPLC using an alkaline solvent system. This method is capable of rapidly and efficiently extracting and separating PGI2 and 6-K-PGF1 alpha from whole blood or plasma. It introduces less than 5% hydrolysis of PGI2, thus providing a means of applying highly sensitive 6-K-PGF1 alpha assays to the determination of PGI2 levels in physiological samples.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7029655     DOI: 10.1016/0090-6980(81)90099-x

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  4 in total

1.  Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasma.

Authors:  K Nara; H Odagiri; M Fujii; Y Yamanaka; M Yokoyama; T Morita; M Sasaki; M Kon; T Abo
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Augmentation of endotoxin fever by recombinant human beta interferon in rabbits.

Authors:  H Kawasaki; M Moriyama; A Tanaka
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

3.  Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension.

Authors:  Olivier Lambert; Dirk Bandilla
Journal:  Drug Des Devel Ther       Date:  2012-09-17       Impact factor: 4.162

4.  Stability and microbiological properties of a new formulation of epoprostenol sodium when reconstituted and diluted.

Authors:  Olivier Lambert; Dirk Bandilla; Rupa Iyer; Leonore Witchey-Lakshmanan; Nagesh Palepu
Journal:  Drug Des Devel Ther       Date:  2012-03-28       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.